"That we observed this response using multiple aggressive ovarian cancer cell lines suggests that inhibiting this pathway has potential to enhance clinical outcomes for ovarian cancer patients." ...

"That we observed this response using multiple aggressive ovarian cancer cell lines suggests that inhibiting this pathway has potential to enhance clinical outcomes for ovarian cancer patients." ...

The peritoneum is a layer of thin tissue that lines the inside of the tummy (abdomen ... ovarian cancer at the same time as a separate womb (endometrial) cancer. Clear cell ovarian cancer can also be ...

BRCA1 and BRCA2 genes play a crucial role in repairing damaged DNA. Mutations in BRCA1 and BRCA2 substantially increase the likelihood of breast and ovarian cancer, respectively. This new research ...

This comprehensive review revealed compelling evidence for stenoparib's durable clinical benefit in platinum-resistant, advanced ovarian cancer patients ... resistant human cancer cell lines, ...

"That we observed this response using multiple aggressive ovarian cancer cell lines suggests that inhibiting this pathway has potential to enhance clinical outcomes for ovarian cancer patients." ...

Allarity Therapeutics, Inc. ("Allarity” or the "Company”) (NASDAQ: ALLR), a Phase 2 clinical-stage pharmaceutical company ...

Women firefighters, who face a greater risk of some cancers, fought for years to get coverage for their potential illnesses.

The research shows how gold-based compounds can be used in a new way to fight cancer — and potentially other diseases, says ...